Leerink Partnrs Cuts Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Leerink Partnrs decreased their Q3 2025 earnings per share (EPS) estimates for shares of Henry Schein in a report released on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $1.20 for the quarter, down from their previous estimate of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $4.96 EPS and FY2027 earnings at $5.48 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the firm earned $0.66 EPS. The business’s revenue for the quarter was up 5.8% on a year-over-year basis.

Other research analysts have also issued research reports about the company. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. StockNews.com raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday, April 9th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. Five analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Price Performance

Henry Schein stock opened at $65.61 on Monday. The business has a fifty day moving average price of $71.58 and a 200-day moving average price of $72.19. The firm has a market capitalization of $8.15 billion, a P/E ratio of 27.00, a PEG ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a one year low of $60.56 and a one year high of $82.49.

Insider Activity

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently added to or reduced their stakes in HSIC. Invesco Ltd. boosted its holdings in shares of Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock worth $343,468,000 after purchasing an additional 17,552 shares during the period. FMR LLC raised its holdings in shares of Henry Schein by 6.6% during the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after acquiring an additional 217,143 shares in the last quarter. Geode Capital Management LLC lifted its stake in Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after acquiring an additional 14,876 shares during the period. Palestra Capital Management LLC purchased a new position in Henry Schein during the 4th quarter valued at $182,988,000. Finally, Fiduciary Management Inc. WI lifted its position in shares of Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after purchasing an additional 167,990 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.